Close Menu

NEW YORK (GenomeWeb) – Bruker announced this week that it has completed its previously announced acquisition of an 80 percent majority interest in Nehren, Germany-based Hain Lifescience. Hain is a provider of molecular diagnostics for the detection of microbial and viral pathogens, as well as for molecular antibiotic resistance testing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.